Brief: Puma Biotechnology Q1 Adjusted EPS USD -0.05
02/05/2024 21:05
May 02 (Reuters) - Puma Biotechnology Q1 product revenue USD 40.3 million. * Q1 adjusted net income USD -4.6 million * Q1 operating income USD -2.3 million * Q1 net income USD -4.8 million * Q1 EPS USD -0.1
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2